Jennison Associates LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Jennison Associates LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 06, 2019	SELL	$8.63 - $12.4 $10.9 Million - $15.7 Million	-1,263,978 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$9.6 - $12.9 $71,779 - $96,453	7,477 Added 0.6%	1,263,978 $15.2 Million
Q2 2018 Aug 02, 2018	BUY	$8.3 - $16.8 $5.03 Million - $10.2 Million	606,361 Added 93.27%	1,256,501 $15.3 Million
Q1 2018 Apr 20, 2018	BUY	$8.1 - $16.0 $371,360 - $733,552	45,847 Added 7.59%	650,140 $6.4 Million
Q4 2017 Jan 25, 2018	BUY	$10.5 - $14.15 $6.35 Million - $8.55 Million	604,293	604,293 $8.43 Million

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.